81 related articles for article (PubMed ID: 19582431)
1. Dendritic cell vaccines for cancer stem cells.
Pellegatta S; Finocchiaro G
Methods Mol Biol; 2009; 568():233-47. PubMed ID: 19582431
[TBL] [Abstract][Full Text] [Related]
2. Neurospheres enriched in cancer stem-like cells are highly effective in eliciting a dendritic cell-mediated immune response against malignant gliomas.
Pellegatta S; Poliani PL; Corno D; Menghi F; Ghielmetti F; Suarez-Merino B; Caldera V; Nava S; Ravanini M; Facchetti F; Bruzzone MG; Finocchiaro G
Cancer Res; 2006 Nov; 66(21):10247-52. PubMed ID: 17079441
[TBL] [Abstract][Full Text] [Related]
3. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells.
Yi L; Zhou C; Wang B; Chen T; Xu M; Xu L; Feng H
Int J Oncol; 2013 Aug; 43(2):477-84. PubMed ID: 23708048
[TBL] [Abstract][Full Text] [Related]
4. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma.
Wu A; Oh S; Gharagozlou S; Vedi RN; Ericson K; Low WC; Chen W; Ohlfest JR
J Immunother; 2007; 30(8):789-97. PubMed ID: 18049330
[TBL] [Abstract][Full Text] [Related]
5. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
7. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas.
Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC
Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624
[TBL] [Abstract][Full Text] [Related]
8. Identification of cancer stem cells in dog glioblastoma.
Stoica G; Lungu G; Martini-Stoica H; Waghela S; Levine J; Smith R
Vet Pathol; 2009 May; 46(3):391-406. PubMed ID: 19176492
[TBL] [Abstract][Full Text] [Related]
9. [Study on the specific immunity induced by dendritic cell vaccine loading allogenic microvascular endothelial cell bEnd.3 antigen against U14 cervical cancer cell in mice].
Zhao J; Lu J; Liu YQ; Yang HY; Huang YT; Zhao JM; Li S; Zhai JM; Zhao MY; Zhang X; Dong ZM
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):52-7. PubMed ID: 21429436
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapeutic targeting of shared melanoma-associated antigens in a murine glioma model.
Prins RM; Odesa SK; Liau LM
Cancer Res; 2003 Dec; 63(23):8487-91. PubMed ID: 14679014
[TBL] [Abstract][Full Text] [Related]
11. Improved therapeutic efficacy using vaccination with glioma lysate-pulsed dendritic cells combined with IP-10 in murine glioma.
Jiang XB; Lu XL; Hu P; Liu RE
Vaccine; 2009 Oct; 27(44):6210-6. PubMed ID: 19699331
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenoma stem cells.
Tunici P; Yu JS
Methods Mol Biol; 2009; 568():195-201. PubMed ID: 19582428
[TBL] [Abstract][Full Text] [Related]
13. A tumorigenic subpopulation with stem cell properties in melanomas.
Fang D; Nguyen TK; Leishear K; Finko R; Kulp AN; Hotz S; Van Belle PA; Xu X; Elder DE; Herlyn M
Cancer Res; 2005 Oct; 65(20):9328-37. PubMed ID: 16230395
[TBL] [Abstract][Full Text] [Related]
14. Tumor specific cytotoxicity and telomerase down-regulation in prostate cancer by autologous dendritic cells loaded with whole tumor cell antigens.
Turkeri L; Onol FF; Ozyurek M
Urol Oncol; 2010; 28(3):290-5. PubMed ID: 19362861
[TBL] [Abstract][Full Text] [Related]
15. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
16. Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination.
Liu G; Black KL; Yu JS
Expert Rev Vaccines; 2006 Apr; 5(2):233-47. PubMed ID: 16608423
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.
Pellegatta S; Poliani PL; Corno D; Grisoli M; Cusimano M; Ubiali F; Baggi F; Bruzzone MG; Finocchiaro G
Neurol Res; 2006 Jul; 28(5):527-31. PubMed ID: 16808884
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting.
Hu Y; Lu L; Xia Y; Chen X; Chang AE; Hollingsworth RE; Hurt E; Owen J; Moyer JS; Prince ME; Dai F; Bao Y; Wang Y; Whitfield J; Xia JC; Huang S; Wicha MS; Li Q
Cancer Res; 2016 Aug; 76(16):4661-72. PubMed ID: 27325649
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor immunity by murine cytokine activated T lymphocytes after cocultured with bone marrow derived dendritic cells pulsed with whole tumor lysates.
Zhang S; Wang Q; Li WF; Wang HY; Zhang HJ
Leuk Res; 2004 Oct; 28(10):1085-8. PubMed ID: 15289022
[TBL] [Abstract][Full Text] [Related]
20. [Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].
Ge W; Li CH; Zhang W; Han Q; Deng WM; Chen L; You SG; Zhao CH
Zhonghua Xue Ye Xue Za Zhi; 2004 May; 25(5):277-80. PubMed ID: 15182535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]